Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Ioffe

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|September 2, 2021
Analytical scientist in pharmaceutical company: My thirty years in analytical R&DVladimir Ioffe
The Journal of Urology|December 18, 2019
Re: Personalized Risks of Over Diagnosis for Screen Detected Prostate Cancer Incorporating Patient Comorbidities: Estimation and CommunicationR. Gulati, S. P. Psutka and R. Etzioni <i>J Urol</i> 2019; <b>202:</b> 936-943Navin Shah, Vladimir Ioffe
Reviews in Urology|November 26, 2020
A Trend Toward Aggressive Prostate CancerNavin Shah, Vladimir Ioffe
The Journal of Urology|May 13, 2021
Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance-Does Magnetic Resonance Imaging Have a Role? LetterNavin Shah, Vladimir Ioffe
The Journal of Urology|May 30, 2023
Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation. LetterNavin Shah, Vladimir Ioffe
Urology|March 25, 2018
Re: Vetterlein et al.: State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update (Urology 2018;112:56-65)Navin Shah, Vladimir Ioffe
The Journal of Urology|April 11, 2023
Long-term Outcomes Following Active Surveillance of Low-grade Prostate Cancer: A Population-based Study Using a Landmark Approach. LetterNavin Shah, Vladimir Ioffe
The Journal of Urology|September 6, 2023
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening. LetterNavin Shah, Vladimir Ioffe
Reviews in Urology|September 30, 2017
The association between hypertension and prostate cancerShah Navin, Vladimir Ioffe
Urology|April 6, 2021
Re: Letter to the Editor: Generalizability of Prostate-Specific Antigen (PSA) Screening Trials in a "Real World" Setting: A Nationwide Survey Analysis. Deepansh Dalela et al. (Urology 2021;148:1-3)Navin Shah, Vladimir Ioffe
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical and Biomedical Analysis|September 2, 2021
Analytical scientist in pharmaceutical company: My thirty years in analytical R&DVladimir Ioffe
The Journal of Urology|December 18, 2019
Re: Personalized Risks of Over Diagnosis for Screen Detected Prostate Cancer Incorporating Patient Comorbidities: Estimation and CommunicationR. Gulati, S. P. Psutka and R. Etzioni <i>J Urol</i> 2019; <b>202:</b> 936-943Navin Shah, Vladimir Ioffe
Reviews in Urology|November 26, 2020
A Trend Toward Aggressive Prostate CancerNavin Shah, Vladimir Ioffe
The Journal of Urology|May 13, 2021
Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance-Does Magnetic Resonance Imaging Have a Role? LetterNavin Shah, Vladimir Ioffe
The Journal of Urology|May 30, 2023
Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation. LetterNavin Shah, Vladimir Ioffe
Urology|March 25, 2018
Re: Vetterlein et al.: State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update (Urology 2018;112:56-65)Navin Shah, Vladimir Ioffe
The Journal of Urology|April 11, 2023
Long-term Outcomes Following Active Surveillance of Low-grade Prostate Cancer: A Population-based Study Using a Landmark Approach. LetterNavin Shah, Vladimir Ioffe
The Journal of Urology|September 6, 2023
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening. LetterNavin Shah, Vladimir Ioffe
Reviews in Urology|September 30, 2017
The association between hypertension and prostate cancerShah Navin, Vladimir Ioffe
Urology|April 6, 2021
Re: Letter to the Editor: Generalizability of Prostate-Specific Antigen (PSA) Screening Trials in a "Real World" Setting: A Nationwide Survey Analysis. Deepansh Dalela et al. (Urology 2021;148:1-3)Navin Shah, Vladimir Ioffe
Pageof 3